Craig Panos, MD
Family Medicine · Coeur D Alene, IDNPI 1104855188
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 27.5% of the total. Reporting peaked in 2019 at $341 and has fallen 61.5% since, to $131 in 2024.
Across 81 payments — averaging $17.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$381
- Johnson & Johnson$229
- Lilly USA, LLC$140
- AstraZeneca$137
- Boehringer Ingelheim$85
- Pfizer$76
- plus $338 from 11 others
What the payments were for
- Food & beverage$1,385100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 21 | $381 |
| Johnson & Johnson | 13 | $229 |
| Lilly USA, LLC | 8 | $140 |
| AstraZeneca | 9 | $137 |
| Boehringer Ingelheim | 6 | $85 |
| Pfizer | 5 | $76 |
| Amgen(2 entities) | 3 | $50 |
| GSK | 3 | $48 |
| Sunovion Pharmaceuticals Inc. | 2 | $46 |
| Exact Sciences | 2 | $44 |
| Novo Nordisk | 2 | $33 |
| Sanofi-aventis U.S. LLC | 2 | $30 |
| Novartis | 1 | $24 |
| Amarin Pharma, Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Bayer | 1 | $12 |
How this compares
$1,385 in reported general payments places this provider in the 75th percentile of 803 family medicine providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Emgality PenGalcanezumab-Gnlm | 12 | $8,119 |
| Aripiprazole | 12 | $634 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $426 |
| Rosuvastatin Calcium | 12 | $142 |
| Amitriptyline Hcl | 16 | $103 |
| Fluoxetine Hcl | 14 | $98 |
| Levothyroxine Sodium | 12 | $42 |
| Lorazepam | 36 | $40 |
| Buspirone Hcl | 11 | $35 |
| Pantoprazole Sodium | 13 | $34 |
| Omeprazole | 16 | $27 |
| Tamsulosin Hcl | 13 | $18 |
| Clonazepam | 15 | $18 |
| Lamotrigine | 12 | $17 |
| Benazepril Hcl | 12 | $14 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Coeur D Alene
- Henry DownsCoeur D Alene$69K
- Crystal PyrakCoeur D Alene$46K
- Douglas LinfordCoeur D Alene$6K
- Alyssa ShawCoeur D Alene$5K
- Kelly NelsonCoeur D Alene$4K
- Kenneth CongerSandpoint$266K
- David ButukMeridian$206K
- Anne BroadwayIdaho Falls$184K
- Timothy McHughMeridian$165K
- Phyllis YouBoise$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.